© 2006 American Thoracic Society
Association between Adrenal Insufficiency and Ventilator WeaningFrom the Authors:
With regard to our recent article (1), Dr. Dimopoulou points out that hydrocortisone supplementation may increase weaning success not only by providing hemodynamic stability but also by suppressing cytokine concentrations, especially tumor necrosis factor- In our study, severity of illness (APACHE III) and percentage of patients with sepsis did not show differences between the corticosteroid and the placebo groups. Therefore, it is difficult to conclude that the cytokine levels were different between the two groups. Although we agree that alteration of the cytokine milieu by hydrocortisone in critical illness might plausibly contribute to weaning success, this point requires further investigation. It is true that our observation may have a significant therapeutic impact, regardless of the complexity of weaning mechanisms. Recently, studies also suggest that activation of the hypothalamicpituitaryadrenal axis is an important protective response during critical illness. Untreated adrenal insufficiency may lead to hemodynamic instability and poor outcome (3). The interest of this new approach was confirmed by the demonstration that a single intravenous administration of 50 mg of hydrocortisone improved doseresponse relationships of mean arterial pressure to norepinephrine and phenylephrine in patients with septic shock (4), particularly in those with relative adrenal insufficiency. These findings support our speculation that hydrocortisone supplementation increases weaning success by improving hemodynamic stability. Regarding other possible confounding variables that were not included in our analysis, but might affect the association between adrenal insufficiency and ventilator weaning, we agree that additional study is warranted to better define the actual effects of hydrocortisone supplementation on these critically ill patients. Perhaps, the balance between steroids and inflammatory mediators (such as cytokines) can be determined with a randomized placebo-controlled trial of physiologic stressdose corticosteroids in critically ill patients with adrenal insufficiency.
Chang Gung Memorial Hospital Chang Gung University, Taoyuan, Taiwan FOOTNOTES Conflict of Interest Statement: Neither author has a financial relationship with a commercial entity that has an interest in the subject of this manuscript. REFERENCES
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||